Rheumatoid arthritis and cardiovascular complications;Rheumatoide arthritis und kardiovaskuläre komplikationen

Zeitschrift fur Rheumatologie

Volumn 65, Issue 6, 2006, Pages 482-486

  Seidel, W ^a   Hecker, M ^a   Wagner, U ^a   Hantzschel H ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Cardiovascular disease; Complications; Cytokines; Mortality; Rheumatoid arthritis

Indexed keywords

ACETYLSALICYLIC ACID; ACUTE PHASE PROTEIN; ANTIRHEUMATIC AGENT; CYTOKINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT;

CARDIOVASCULAR DISEASE; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; MORBIDITY; MORTALITY; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COMORBIDITY; GLUCOCORTICOIDS; HUMANS; PROGNOSIS; RISK FACTORS;

EID: 33750343680     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00393-006-0103-y     Document Type: Review

References (44)

1. Banks MJ, Flint J, Bacon PA et al. (1998) Expression and prevalence of ischaemic heart disease in rheumatid arthritis. Arthritis Rheum 41: S209
2. Bernatsky S, Hudson M, Suissa S (2005) Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis. Rheumatology (Oxford) 44: 677-680
3. Choi HK, Hernan MA, Seeger JD et al. (2002) Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 359: 1173-1177
4. Colgazier L, Wolfe F, Michaud K (2005) Rheumatoid arthritis patients are less likely to be treated with prophylactic aspirin despite an increased risk of myocardial infarction. Arthritis Rheum 52: S704
5. Davis JM, Maradit-Kremers H, Crowson CS et al. (2005) Cumulative glucocorticoid exposure and the risk of cardiovascular events in a population-based cohort of rheumatoid arthritis subjects. Arthritis Rheum 52: S704
6. Dessein PH, Joffe BI, Singh S (2005) Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther 7: R634-R643
7. Del Rincon I, O'Leary DH, Haas RW et al. (2004) Effect of glucocorticoids on the arteries in rheumatoid arthritis. Arthritis Rheum 50: 3813-3822
8. Del Rincon I, Freeman GL, Haas RW et al. (2005) Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis. Arthritis Rheum 52: 3413-3423
9. Ferraccioli G, Zoli A, Alivernini S et al. (2006) Lupus anticoagulant and ischemic myocardial microangiopathy in rheumatoid arthritis. Nat Clin Pract Cardiovasc Med 3: 339-343
10. Fichtlscherer S, Rosenberger G, Walter DH et al. (2000) Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 102: 1000-1006
11. Fischer LM, Schlienger RG, Matter CM et al. (2004) Discontinuation of nonsteroidal anti-inflammatory drug therapy and risk of acute myocardial infarction. Arch Intern Med 164: 2472-2476
12. Geiler G (1970) Morphologie und Pathogenese der progressiv chronischen Polyarthritis. Wiss Z Karl-Marx-Uni Leipzig Math-Naturwiss Reihe 19: 547-557
13. Giles JT, Fernandes V, Lima JA et al. (2005) Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis. Arthritis Res Ther 7: 195-207
14. Goodson N (2002) Coronary artery disease and rheumatoid arthritis. Curr Opin Rheumatol 14: 115-120
15. Goodson NJ, Wiles NJ, Lunt M et al. (2001) Increased mortality in seropositive patients during the early years of inflammatory polyarthritis. Rheumatology [Suppl 1] 40: 71-71
16. Goodson NJ, Symmons DP, Scott DG et al. (2005) Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year follow-up study of a primary care-based inception cohort. Arthritis Rheum 52: 2293-2299
17. Hagendorff A, Pfeiffer D (2005) Echokardiographische Funktionsdiagnostik bei Patienten mit rheumatischer Arthritis und Kollagenosen. Z Rheumatol 64: 239-248
18. Henke R, Allouch V, Häntzschel H (1992), Herzbeteiligung. In: Häntzschel H, Otto W, Nasonova V (Hrgs) Rheumatoide Arthritis - eine systemische Erkrankung. Barth, Leipzig, S 150-153
19. Hürlimann D, Forster A, Noll G et al. (2002) Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 106: 2184-2187
20. Iverson PO (1999) Human cytokines modulate arterial vascular tone via endothelial receptors. Pflugers Arch 439: 93-100
21. Jacobsson LT, Turesson C, Gulfe A et al. (2005) Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J Rheumatol 32: 1213-1218
22. Johnson SP, Larsson H, Tarone RE et al. (2005) Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study. Arch Intern Med 165: 978-984
23. Krause D, Schleusser B, Herborn G et al. (2000) Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis. Arthritis Rheum 43: 14-21
24. Lagrand WK, Visser CA, Hermens WT et al. (1999) C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation 100: 96-102
25. Libby M, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105: 1135-1143
26. Liebscher K, Weise M, Henßge R et al. (1986) Herzbeteiligung bei Rheumatoid-Arthritis. Z Gesamt Inn Med 41: 634-636
27. Maradit-Kremers H, Crowson CS, Nicola PJ et al. (2005) Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 52: 402-411
28. Moritz F, Wagner U, Distler O et al. (2005) Kardiovasculäre Manifestation bei Rheumatoider Arthritis. Z Rheumatol 64: 222-228
29. Nicola PJ, Maradit-Kremers H, Roger VL et al. (2005) The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum 52: 412-420
30. Nicola PJ, Crowson CS, Maradit-Kremers H et al. (2006) Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis. Arthritis Rheum 54: 60-67
31. Pasceri V, Yeh ET (1999) A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation 100: 2124-2126
32. Pincus T, Callahan LFD (1986) Taking mortality in rheumatoid arthritis seriously - predictive markers, socioeconomic status and comorbidity. J Rheumatol 13: 841-841
33. Pincus T, Callahan LF, Sale WG (1984) Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 27: 864-872
34. Raitakari OT, Celermajer DS (2000) Flow-mediated dilatation. Br J Clin Pharmacol 50: 397-404
35. Rattazzi M, Puato M, Faggin E et al. (2003) C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders? J Hypertens 21: 1787-1803
36. Raza K, Banks M, Kitas GD (2005) Reversing myocardial microvascular disease in a patient with rheumatoid arthritis. J Rheumatol 32: 754-756
37. Seidel W, Pierer M, Häntzschel H (2004) Internistische Therapie der rheumatoiden Arthritis. Internist 45: 693-706
38. Situnayake RD, Kitas G (1997) Dyslipidemia and rheumatoid arthritis. Ann Rheum Dis 56: 341-342
39. Solomon DH, Curhan GC, Rimm EB et al. (2004) Cardiovascular risk factors in women with and without rheumatoid arthritis. Arthritis Rheum 50: 3444-3449
40. Vollertsen RS, Conn DL (1990) Vasculitis associated with rheumatoid arthritis. Rheum Dis Clin North Am 16: 445-461
41. Wallberg-Jonsson S, Johansson H, Ohman ML et al. (1999) Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J Rheumatol 26: 2562-2571
42. Warrington KJ, Kent PD, Frye RL et al. (2005) Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study. Arthritis Res Ther 7: R984-991
43. Wolfe F, Mitchell DM, Sibley JT et al. (1994) The mortality in rheumatoid arthritis. Arthritis Rheum 37: 481-494
44. Yeh ET (2004) CRP as a mediator of disease. Circulation 109: II11-II14